Ronald Crystal
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$2.5MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 6, 2022 | NIH | STTR Phase I Anti-eosinophil Gene Therapy for Eosinophilic Esophagitis | $300K | ENYX THERAPEUTICS LLC with WEILL MEDICAL COLL OF CORNELL UNIV |
| Jul 1, 2020 | NIH | STTR Phase I Gene Therapy to Treat Ethanol-induced Osteoporosis Associated with Aldehyde Dehydrogenase 2 Deficiency | $252K | LEXEO Therapeutics LLC with WEILL MEDICAL COLL OF CORNELL UNIV |
| Sep 23, 2019 | NIH | STTR Phase I Gene Therapy to Protect the Lung from Oxidant Stress | $225K | LEXEO Therapeutics LLC with WEILL MEDICAL COLL OF CORNELL UNIV |
| Jun 1, 2019 | NIH | STTR Phase II Oxidation-resistant Anti-protease Therapy | $1.5M | LEXEO Therapeutics LLC with WEILL MEDICAL COLL OF CORNELL UNIV |
| Jun 1, 2019 | NIH | STTR Phase I Gene Therapy to Prevent Esophageal Cancer Associated with Aldehyde Dehydrogenase Deficiency | $225K | LEXEO Therapeutics LLC with WEILL MEDICAL COLL OF CORNELL UNIV |
Peer ranks
Federal funding#770
Awards as PI#417
Patents#273
Companies
- ENYX THERAPEUTICS LLCLinked by awards · Biotech
- LEXEO Therapeutics LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.